Emergent CDMO
400 Professional Drive, Suite 400
Gaithersburg, MD 20879
T: +1 (800) 441-4225 
E: 
cdmo@ebsi.com
W: 
https://emergentCDMO.com
LinkedIn: 
https://www.linkedin.com/showcase/emergent-biosolutions-cdmo


Synchronized to Serious Science. Yours.

Emergent CDMO is the contract development and manufacturing (CDMO) arm of Emergent (NYSE: EBS). Emergent CDMO has the scientific and regulatory compliance experience, end-to-end development and manufacturing expertise, and efficient technology transfer capabilities that can harness the urgency, acuity, and scalability required to bring life-saving, life-extending products to market. Even when the world changes around us and new challenges emerge, our mission stays the same — to improve and protect the health of billions of people around the globe by supporting innovative drug makers that make the seemingly impossible possible. We understand that which approach fits you best can be found where science and business strategy intersect, where dynamics like speed, cost, and regulatory approach are balanced in precise harmony. And as an integrated CDMO with the experience of an established biopharmaceutical company, Emergent stands ready to help reach your next clinical or commercial drug product milestone.

Development & Manufacturing Solutions for Biologics

Emergent BioSolutions’ mission is to protect and enhance life through innovation. Over the last few decades, Emergent has developed, manufactured, and delivered therapeutics and vaccines throughout the world to tackle the most serious health threats.

Emergent’s CDMO business draws on this experience and has supported the development and manufacture of over 40 commercial products approved for distribution in over 70 countries, as well as clinical trial material for a wide range of early to late phase programs. Since 1998, our global manufacturing network has supported over 100 drug product candidates, making Emergent a proven partner for pharmaceutical and biotechnology companies looking for value and reliability through outsourcing.

Technologies & Platforms for Every Strategy

Our CDMO teams have flexible and scalable technology platforms able to support clinical through commercial manufacturing.

Development Services

  • Process Development
  • Analytical Development
  • Formulation Development
  • Non-GMP Lab-Scale Manufacturing

Drug Substance Manufacturing

  • Upstream & Downstream
  • Single-Use Platform (up to 4000L)
  • Mammalian Cell Culture
  • Process & Analytical Development
  • Clinical & Commercial Scale

Drug Product Manufacturing

  • Vials and Prefilled Syringes
  • Packaging & Labeling
  • Viral & Non-Viral Fill/Finish
  • Biologics
  • Parenteral Formulation Development
  • Clinical & Commercial Scale
  • Liquid & Lyophilized Products
  • Microbiology
  • ICH Stability

Wherever you are in your journey, whatever challenges you face, our team of experts and resources are ready to go to work for you.

Let’s get started with your next clinical or commercial candidate. Your new formula for success awaits.

Recent Webinars

Large Molecule Outsourced Pharma Capacity Update

High-Speed Viral Drug Product Manufacturing

Enhancing our Capabilities for Aseptic Fill/Finish Processing: Introducing the Groninger FlexPro 50

Bridging the Gap Between R&D and Manufacturing

Whitepapers

How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines

Streamlining Your Process Development Journey to GMP Manufacturing
Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Lyophilized Products Are on the Rise: Here’s What You Need to Know